» Articles » PMID: 22669285

Biocompatibility and Biodegradation Studies of PCL/β-TCP Bone Tissue Scaffold Fabricated by Structural Porogen Method

Overview
Publisher Springer
Date 2012 Jun 7
PMID 22669285
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Three-dimensional printer (3DP) (Z-Corp) is a solid freeform fabrication system capable of generating sub-millimeter physical features required for tissue engineering scaffolds. By using plaster composite materials, 3DP can fabricate a universal porogen which can be injected with a wide range of high melting temperature biomaterials. Here we report results toward the manufacture of either pure polycaprolactone (PCL) or homogeneous composites of 90/10 or 80/20 (w/w) PCL/beta-tricalcium phosphate (β-TCP) by injection molding into plaster composite porogens fabricated by 3DP. The resolution of printed plaster porogens and produced scaffolds was studied by scanning electron microscopy. Cytotoxicity test on scaffold extracts and biocompatibility test on the scaffolds as a matrix supporting murine osteoblast (7F2) and endothelial hybridoma (EAhy 926) cells growth for up to 4 days showed that the porogens removal process had only negligible effects on cell proliferation. The biodegradation tests of pure PCL and PCL/β-TCP composites were performed in DMEM with 10 % (v/v) FBS for up to 6 weeks. The PCL/β-TCP composites show faster degradation rate than that of pure PCL due to the addition of β-TCP, and the strength of 80/20 PCL/β-TCP composite is still suitable for human cancellous bone healing support after 6 weeks degradation. Combining precisely controlled porogen fabrication structure, good biocompatibility, and suitable mechanical properties after biodegradation, PCL/β-TCP scaffolds fabricated by 3DP porogen method provide essential capability for bone tissue engineering.

Citing Articles

Polycaprolactone in Bone Tissue Engineering: A Comprehensive Review of Innovations in Scaffold Fabrication and Surface Modifications.

Liang H, Lee W, Hsu J, Shih J, Ma T, Vo T J Funct Biomater. 2024; 15(9).

PMID: 39330219 PMC: 11433047. DOI: 10.3390/jfb15090243.


Extrusion 3D-printed tricalcium phosphate-polycaprolactone biocomposites for quercetin-KCl delivery in bone tissue engineering.

Toulou C, Chaudhari V, Bose S J Biomed Mater Res A. 2024; 112(9):1472-1483.

PMID: 38477071 PMC: 11239310. DOI: 10.1002/jbm.a.37692.


Histological and Immunohistochemical Characterization of Osteoimmunological Processes in Scaffold-Guided Bone Regeneration in an Ovine Large Segmental Defect Model.

Finze R, Laubach M, Serafini M, Kneser U, Medeiros Savi F Biomedicines. 2023; 11(10).

PMID: 37893154 PMC: 10604530. DOI: 10.3390/biomedicines11102781.


Tuning of Silver Content on the Antibacterial and Biological Properties of Poly(ɛ-caprolactone)/Biphasic Calcium Phosphate 3D-Scaffolds for Bone Tissue Engineering.

Menotti F, Scutera S, Coppola B, Longo F, Mandras N, Cavallo L Polymers (Basel). 2023; 15(17).

PMID: 37688244 PMC: 10489712. DOI: 10.3390/polym15173618.


Fabrication and Evaluation of Porous dECM/PCL Scaffolds for Bone Tissue Engineering.

Wang W, Zhou X, Yin Z, Yu X J Funct Biomater. 2023; 14(7).

PMID: 37504838 PMC: 10381742. DOI: 10.3390/jfb14070343.


References
1.
Misch C, Qu Z, Bidez M . Mechanical properties of trabecular bone in the human mandible: implications for dental implant treatment planning and surgical placement. J Oral Maxillofac Surg. 1999; 57(6):700-6; discussion 706-8. DOI: 10.1016/s0278-2391(99)90437-8. View

2.
WOODWARD S, Brewer P, Moatamed F, Schindler A, Pitt C . The intracellular degradation of poly(epsilon-caprolactone). J Biomed Mater Res. 1985; 19(4):437-44. DOI: 10.1002/jbm.820190408. View

3.
Kim H, Knowles J, Kim H . Development of hydroxyapatite bone scaffold for controlled drug release via poly(epsilon-caprolactone) and hydroxyapatite hybrid coatings. J Biomed Mater Res B Appl Biomater. 2004; 70(2):240-9. DOI: 10.1002/jbm.b.30038. View

4.
Fukuhira Y, Kitazono E, Hayashi T, Kaneko H, Tanaka M, Shimomura M . Biodegradable honeycomb-patterned film composed of poly(lactic acid) and dioleoylphosphatidylethanolamine. Biomaterials. 2005; 27(9):1797-802. DOI: 10.1016/j.biomaterials.2005.10.019. View

5.
Zhang Q, Mochalin V, Neitzel I, Knoke I, Han J, Klug C . Fluorescent PLLA-nanodiamond composites for bone tissue engineering. Biomaterials. 2010; 32(1):87-94. DOI: 10.1016/j.biomaterials.2010.08.090. View